Literature DB >> 824466

Mucoid Pseudomonas aeruginosa. A sign of cystic fibrosis in young adults with chronic pulmonary disease?

H Y Reynolds, P A Di Sant'Agnese, C H Zierdt.   

Abstract

Two adult patients with cystic fibrosis had late onset of symptoms with principal involvement only of the lungs. The absence of other typical features of cystic fibrosis confused the diagnosis. Recovery of mucoid Pseudomonas aeruginosa from sputum cultures helped to establish the diagnosis in these patients, because these mucoid isolates are rarely obtained from subjects who do not have cystic fibrosis. Recent findings, which have identified the mucoid isolates as predominantly a single strain of P aeruginosa and have documented its widespread carriage in the United States by patients with cystic fibrosis, point to an interesting epidemiologic relationship between this bacterium and this disease.

Entities:  

Mesh:

Year:  1976        PMID: 824466     DOI: 10.1001/jama.236.19.2190

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  11 in total

1.  Scnn1b-Transgenic BALB/c Mice as a Model of Pseudomonas aeruginosa Infections of the Cystic Fibrosis Lung.

Authors:  Kristen J Brao; Brendan P Wille; Joshua Lieberman; Robert K Ernst; Mark E Shirtliff; Janette M Harro
Journal:  Infect Immun       Date:  2020-08-19       Impact factor: 3.441

2.  Exophiala dermatitidis Revealing Cystic Fibrosis in Adult Patients with Chronic Pulmonary Disease.

Authors:  Frédéric Grenouillet; Bernard Cimon; Heloise Pana-Katatali; Christine Person; Marie Gainet-Brun; Marie-Claire Malinge; Yohann Le Govic; Bénédicte Richaud-Thiriez; Jean-Philippe Bouchara
Journal:  Mycopathologia       Date:  2017-11-01       Impact factor: 2.574

3.  R-factor inheritance and plasmid content in mucoid Pseudomonas aeruginosa.

Authors:  S M Markowitz; F L Macrina; P V Phibbs
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

4.  Effects of airway infection by Pseudomonas aeruginosa: a computed tomographic study.

Authors:  K A Miszkiel; A U Wells; M B Rubens; P J Cole; D M Hansell
Journal:  Thorax       Date:  1997-03       Impact factor: 9.139

Review 5.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09

6.  Genetic mapping of chromosomal determinants for the production of the exopolysaccharide alginate in a Pseudomonas aeruginosa cystic fibrosis isolate.

Authors:  D E Ohman; A M Chakrabarty
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

7.  Phenotypic differences among clinically isolated mucoid Pseudomonas aeruginosa strains.

Authors:  B K Pugashetti; H M Metzger; L Vadas; D S Feingold
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

8.  High osmolarity is a signal for enhanced algD transcription in mucoid and nonmucoid Pseudomonas aeruginosa strains.

Authors:  A Berry; J D DeVault; A M Chakrabarty
Journal:  J Bacteriol       Date:  1989-05       Impact factor: 3.490

9.  Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition.

Authors:  M A Luzar; M J Thomassen; T C Montie
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

10.  A small volatile bacterial molecule triggers mitochondrial dysfunction in murine skeletal muscle.

Authors:  A Aria Tzika; Caterina Constantinou; Arunava Bandyopadhaya; Nikolaos Psychogios; Sangseok Lee; Michael Mindrinos; J A Jeevendra Martyn; Ronald G Tompkins; Laurence G Rahme
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.